| Harmony Home Co. By Heidi | |
|
101 W Mclean St, Alahambra, CA 91801 | |
| (626) 344-8167 | |
| Not Available |
| Full Name | Harmony Home Co. By Heidi |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist - Environmental Modification |
| Location | 101 W Mclean St, Alahambra, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568126183 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
| 225XE0001X | Occupational Therapist - Environmental Modification | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Harmony Home Co. By Heidi 556 S Fair Oaks Ave Ste 101 #120, Pasadena, CA 91105-2656 Ph: () - | Harmony Home Co. By Heidi 101 W Mclean St, Alahambra, CA 91801 Ph: (626) 344-8167 |
News Archive
Northwest Community Healthcare is strengthening cardiovascular care for patients in the northwest suburbs by advancing its cardiovascular service line. NCH has new relationships with cardiothoracic surgeons, vascular surgeons and cardiologists, and, in addition, has announced plans to open a new heart failure clinic this fall in Mount Prospect.
The U.S. Food and Drug Administration today announced that the American Association for Laboratory Accreditation has accredited the Laboratory Quality System program in the Center for Biologics and Evaluation Research (CBER) under ISO/IEC 17025 in the fields of biological and chemical testing.
The Florida Society of Pain Management Providers urges Government, Law Enforcement and the media to stop using false prescription drug data and statistics. The continued release of false and / or out of context information is solely intended to enflame the public. The misinformation that unfairly portrays Florida as ground zero in this issue has significant consequences for pain management patients and the physicians who provide legitimate care.
Knowledge of a newly discovered genetic disorder, which means that a person cannot produce the protein TXNIP (thioredoxin interacting protein) in their cells, can open for the development of new diabetes drugs.
An exploratory randomized, controlled study on the safety and efficacy of either lopinavir/ritonavir (LPV/r) or Arbidol-antivirals that are used in some countries against HIV-1 and to treat influenza , respectively-as treatments for COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, suggests that neither drug improves the clinical outcome of patients hospitalized with mild-to-moderate cases of the disease over supportive care.
› Verified 1 days ago